PIK3CG (p110γ): Uncovering Potential Targets for Mechanistic Studies of Sepsis‑Induced Myocardial Injury

Complex Pathological Landscape of Sepsis‑Associated Myocardial Damage

Sepsis drives systemic inflammatory cascades that frequently progress toward multi‑organ dysfunction syndromes, among which myocardial injury strongly influences experimental‑model survival outcomes. Laboratory statistics demonstrate markedly elevated mortality rates for cohorts exhibiting concurrent myocardial functional impairment compared with injury‑free control groups.

Multiple interconnected molecular events jointly shape this pathological phenotype. Excessive pro‑inflammatory cytokine release disturbs cardiomyocyte calcium homeostasis, impairs mitochondrial bioenergetic performance and promotes reactive‑oxygen‑species accumulation. Simultaneously, diverse regulated‑cell‑death cascades including apoptosis, necroptosis and pyroptosis become hyper‑activated within myocardial tissue compartments. Even with advances in intensive‑care‑oriented experimental‑protocols, therapeutic intervention choices remain limited. Further mechanistic exploration is required to identify actionable molecular targets for sepsis‑myocardial‑injury‑focused basic‑research.

Multi‑Omic Integrated Analysis Pinpoints PIK3CG as a Central Hub Gene

Researchers adopted multi‑layered omics‑driven investigative pipelines to screen core regulatory genes linked to sepsis‑related myocardial pathological alterations. Transcriptomic RNA‑seq profiling compared cardiac‑tissue transcript abundance between sepsis‑model and control animal cohorts, identifying 778 differentially‑expressed gene entries. The top 200 altered transcripts exhibited significant enrichment within immune‑response, signal‑transduction and IL‑17 signalling‑related functional gene‑sets.

Weighted gene co‑expression network analysis constructed correlated gene modules tightly associated with sepsis pathological read‑outs. Target‑prediction datasets sourced from drug‑target databases supplied candidate melatonin‑interacting gene candidates. Intersection analysis across these three independent gene collections built pharmacological protein‑interaction networks containing 66 core gene entities. Within this dataset, PIK3CG achieved high topological‑hub scores, indicating its potential functional importance in governing sepsis‑triggered myocardial‑injury biological processes.

Dual Biological Roles Executed by PIK3CG in Sepsis‑Relevant Myocardial and Immune‑Cell Biology

PIK3CG encodes the p110γ catalytic subunit belonging to class IB PI3‑kinase complexes, acting as central component within PI3K‑AKT signal‑transduction cascades. This kinase exhibits context‑dependent dual functional characteristics under sepsis‑mimicking experimental‑conditions.

Within immune‑cell populations, PIK3CG modulates neutrophil chemotaxis, macrophage activation and pro‑inflammatory‑cytokine secretion, amplifying systemic inflammatory signalling outputs. In cardiomyocyte cellular contexts, the same kinase mediates pro‑survival signal flows regulating cell metabolism, proliferative potential and anti‑apoptotic defence programmes. During sepsis progression, PIK3CG expression and kinase‑activity undergo dynamic shifts, creating a functional balance between hyper‑inflammatory amplification and cardiomyocyte damage‑repair responses. Molecular‑docking simulation outputs suggest melatonin may directly engage PIK3CG structural domains to modulate its intrinsic catalytic performance, offering new mechanistic hypotheses explaining melatonin‑derived myocardial‑protective phenotypes.

Mechanistic Research Applications Enabled by PIK3CG Recombinant Rabbit Monoclonal Antibody

High‑specificity PIK3CG‑targeted recombinant rabbit monoclonal antibody delivers multiple investigative advantages for sepsis‑myocardial‑injury‑oriented basic‑research workflows. Immunoblot experimental set‑ups permit quantitative measurement of PIK3CG protein abundance shifts across distinct pathological phases of sepsis‑model progression.

Immunohistochemistry and immunofluorescence imaging visualize spatial PIK3CG distribution patterns among cardiomyocytes, infiltrating immune‑cells and vascular‑endothelial cell populations within heterogeneous cardiac‑tissue specimens. Detection of PIK3CG phosphorylation status and plasma‑membrane translocation events enables assessment of PI3K‑AKT cascade activation magnitude and temporal‑dynamic profiles. This antibody also supports phenotypic verification during melatonin‑intervention assays, evaluating how compound exposure alters PIK3CG expression and functional‑activity read‑outs. Combined with immunoprecipitation and mass‑spectrometry pipelines, the reagent can capture dynamic PIK3CG‑centred protein‑interaction networks under sepsis‑mimicking experimental‑stimulus conditions.

Pre‑Clinical‑Research Perspectives for PIK3CG‑Oriented Target Exploration

Pre‑clinical animal‑model investigations show melatonin treatment alleviates multiple pathological phenotypes linked to sepsis‑induced myocardial damage and improves cardiac‑functional read‑outs. Such protective biological effects become substantially attenuated within PIK3CG‑deficient experimental‑animal cohorts. These observations support the hypothesis that PIK3CG represents a plausible intervention‑relevant target for sepsis‑myocardial‑injury exploratory‑research.

From drug‑discovery‑oriented basic‑research perspectives, PIK3CG‑specific antibodies serve multiple investigative purposes. They constitute essential target‑validation assay reagents for assessing candidate PIK3CG modulator compound performance. Detection read‑outs built upon this antibody can support high‑throughput compound‑screening workflows. Researchers also explore whether PIK3CG protein‑level or phosphorylation‑status metrics could function as exploratory biomarker candidates reflecting myocardial‑injury severity or therapeutic‑intervention responsiveness. Additional experimental assignments include mechanism‑dissection for candidate modulators and safety‑profile evaluation against normal cardiac‑tissue physiological‑functions.

PIK3CG Recombinant Rabbit mAb Research Reagent from ANT BIO PTE. LTD

ANT BIO PTE. LTD provides PIK3CG Recombinant Rabbit mAb (S0B1448), a target‑specific antibody detecting p110γ (PIK3CG) for inflammation, cardiovascular‑pathology and tumour‑immune‑microenvironment‑focused basic‑research assignments. Every antibody production lot undergoes peptide‑array epitope‑specificity screening and multi‑assay functional‑validation prior to commercial‑product release.

Catalog Table of PIK3CG Research Antibody

Functional‑Validation Characteristics of ANT BIO PTE. LTD S0B1448 Antibody

S0B1448 selectively recognizes PIK3CG p110γ polypeptide with limited cross‑reactivity toward other PI3K catalytic isoforms such as p110α, p110β and p110δ. Validated sample matrices encompass human, mouse and rat‑derived immune‑cell lysates, myocardial‑tissue homogenates and tumour‑microenvironment‑related biological‑specimens. Qualified experimental workflows include Western‑blot protein‑abundance quantification, immunofluorescence / IHC tissue‑section localization profiling and immunoprecipitation capturing endogenous PIK3‑associated multi‑protein complexes. Recombinant‑antibody manufacturing yields consistent lot‑to‑lot performance supporting repeatable signalling‑dynamic‑monitoring in immunology‑cardiology‑oriented laboratory‑environments.

Core Fundamental‑Research Applications for PIK3CG Recombinant Rabbit mAb

1. Western‑blot quantification of PIK3CG (p110γ) protein abundance and phosphorylation‑status changes across sepsis‑progression‑stage myocardial‑tissue‑specimen cohorts

2. Immunofluorescence‑IHC spatial‑distribution profiling of endogenous PIK3CG among cardiomyocytes, macrophages and vascular‑endothelial cells within cardiac‑tissue sections

3. Immunoprecipitation‑coupled mass‑spectrometry profiling for dynamic PIK3CG‑centred interactome remodelling under systemic‑inflammation‑mimicking experimental‑stimulus‑conditions

4. Pharmacodynamic biomarker read‑out evaluating cellular‑tissue responses toward melatonin or small‑molecule PIK3CG‑modulator compound‑intervention pre‑clinical‑basic‑research‑campaigns

5. Immune‑cell‑biology mechanistic‑research dissecting PIK3‑γ‑driven signalling governing neutrophil‑macrophage chemotaxis, activation and pro‑inflammatory‑cytokine‑secretion outputs

6. Orthogonal signal‑validation paired with downstream p‑AKT detection for comprehensive multi‑read‑out evaluation of PI3K‑γ‑dependent signalling‑cascade activation states in cardiovascular‑ and tumour‑immune‑microenvironment‑model‑systems

Global Manufacturing & Compliance Standards

S0B1448 antibody batches complete epitope‑specificity profiling including isoform‑cross‑reactivity assessment and multi‑platform functional‑performance‑verification prior to commercial‑product release. Manufacturing facilities adhere to ISO9001, ISO13485 and EU 98/79/EC certification specifications governing life‑science‑research‑reagent‑production‑protocols. In‑house application‑science teams supply detailed immuno‑assay‑SOP documents and curated PIK3CG‑sepsis‑myocardial‑injury‑signal‑transduction‑reference‑publication‑resources. The broader reagent ecosystem includes additional PTM‑detection antibodies, recombinant‑proteins and ELISA‑kits supporting comprehensive inflammation‑cardiovascular multi‑omics‑research pipelines.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANT BIO PTE. LTD., we are committed to advancing life science research through high‑quality, reliable reagents and comprehensive solutions. Our specialized sub‑brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer‑centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.